FASAILLA Trademark

Trademark Overview

On Friday, October 25, 2013, a trademark application was filed for FASAILLA with the United States Patent and Trademark Office. The USPTO has given the FASAILLA trademark a serial number of 86101458. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, May 15, 2017. This trademark is owned by Pfizer Inc.. The FASAILLA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of cardiovascular, central nervous system, endocrine, gastrointestinal, genetic immunological, infectious, inflammatory, menopausal, metabolic, autoimmune, musculoskeletal, neurological, ophthalmological, psychiatric, respiratory, urogenital, urological and viral diseases and disorders; pharmaceutical preparations for the treatment of erectile dysfunction, sexual dysfunction, cancer, pain and diabetes; pharmaceutical preparations for use in hematology; pharmaceutical preparations, namely, antifungal preparations, dermatological preparations, smoking cessation preparations, and tissue repair preparations; vaccines for human use
fasailla

General Information

Serial Number86101458
Word MarkFASAILLA
Filing DateFriday, October 25, 2013
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, May 15, 2017
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 11, 2014

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of cardiovascular, central nervous system, endocrine, gastrointestinal, genetic immunological, infectious, inflammatory, menopausal, metabolic, autoimmune, musculoskeletal, neurological, ophthalmological, psychiatric, respiratory, urogenital, urological and viral diseases and disorders; pharmaceutical preparations for the treatment of erectile dysfunction, sexual dysfunction, cancer, pain and diabetes; pharmaceutical preparations for use in hematology; pharmaceutical preparations, namely, antifungal preparations, dermatological preparations, smoking cessation preparations, and tissue repair preparations; vaccines for human use

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, October 31, 2013
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NamePfizer Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10017
Party NamePfizer Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10017

Trademark Events

Event DateEvent Description
Monday, May 15, 2017ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, May 15, 2017ABANDONMENT - NO USE STATEMENT FILED
Tuesday, September 27, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Saturday, September 24, 2016EXTENSION 5 GRANTED
Monday, September 19, 2016EXTENSION 5 FILED
Monday, September 19, 2016TEAS EXTENSION RECEIVED
Tuesday, April 19, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, April 18, 2016EXTENSION 4 GRANTED
Friday, March 11, 2016EXTENSION 4 FILED
Thursday, April 14, 2016CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, March 11, 2016TEAS EXTENSION RECEIVED
Thursday, October 1, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, September 30, 2015EXTENSION 3 GRANTED
Friday, September 25, 2015EXTENSION 3 FILED
Friday, September 25, 2015TEAS EXTENSION RECEIVED
Tuesday, May 5, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Saturday, May 2, 2015EXTENSION 2 GRANTED
Thursday, March 26, 2015EXTENSION 2 FILED
Saturday, May 2, 2015CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, March 26, 2015TEAS EXTENSION RECEIVED
Wednesday, October 1, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, September 29, 2014EXTENSION 1 GRANTED
Monday, September 29, 2014EXTENSION 1 FILED
Monday, September 29, 2014TEAS EXTENSION RECEIVED
Tuesday, April 8, 2014NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, February 11, 2014OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 11, 2014PUBLISHED FOR OPPOSITION
Wednesday, January 22, 2014NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Saturday, January 4, 2014LAW OFFICE PUBLICATION REVIEW COMPLETED
Thursday, January 2, 2014ASSIGNED TO LIE
Friday, December 13, 2013APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, December 12, 2013EXAMINER'S AMENDMENT ENTERED
Thursday, December 12, 2013NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, December 12, 2013EXAMINERS AMENDMENT E-MAILED
Thursday, December 12, 2013EXAMINERS AMENDMENT -WRITTEN
Tuesday, December 10, 2013ASSIGNED TO EXAMINER
Thursday, October 31, 2013NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, October 29, 2013NEW APPLICATION ENTERED IN TRAM

Related Keywords

fasailla preparations pharmaceutical dysfunction treatment cancer diabetes sexual pain disorders diseases